Search in:

Expert Opinion on Investigational Drugs Volume 18, 2009 - Issue 5

Submit an article Journal homepage

228

Views

CrossRef citations to date

Altmetric

Drug Evaluations

The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data

Giovanni Addolorato Catholic University of Rome, Institute of Internal Medicine, L.o A. Gemelli 8, I-00168 Rome, Italy +39 06 3015 4334; +39 06 3550 2775; [email protected]

, MD,

Lorenzo Leggio Catholic University of Rome, Institute of Internal Medicine, L.o A. Gemelli 8, I-00168 Rome, Italy +39 06 3015 4334; +39 06 3550 2775; [email protected]; Brown University Medical School, Center for Alcohol and Addiction Studies, Providence (RI), USA

, MD MSc,

Anna Ferrulli Catholic University of Rome, Institute of Internal Medicine, L.o A. Gemelli 8, I-00168 Rome, Italy +39 06 3015 4334; +39 06 3550 2775; [email protected]

, MD,

Fabio Caputo SS Annunziata Hospital, Department of Internal Medicine, Cento (FE), Italy

, MD PhD &

Antonio Gasbarrini Catholic University of Rome, Medical Pathology, Rome, Italy

, MD

Pages 675-686 | Published online: 21 Apr 2009

Cite this article
https://doi.org/10.1517/13543780902905855

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Gianoulakis C. Implication of endogenous opioids and dopamine in alcoholism: human and basic science studies. Alcohol Alcohol 1996;31:33-42
PubMed Web of Science ®Google Scholar
Tambour S, Quertemont E. Preclinical and clinical pharmacology of alcohol dependence. Fundam Clin Pharmacol 2007;21:9-28
PubMed Web of Science ®Google Scholar
Addolorato G, Leggio L, Abenavoli L, Gasbarrini G. Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav 2005;30:1209-24
PubMed Web of Science ®Google Scholar
Davies M. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. J Psychiatry Neurosci 2003;28:263-74
PubMed Web of Science ®Google Scholar
Nie Z, Madamba SG, Siggins GR. Ethanol inhibits glutamatergic neurotransmission in nucleus accumbens neurons by multiple mechanisms. J Pharmacol Exp Ther 1994;271:1566-73
PubMed Web of Science ®Google Scholar
Aistrup GL, Marszalec W, Narahashi T. Ethanol modulation of nicotinic acetylcholine receptor currents in cultured cortical neurons. Mol Pharmacol 1999;55:39-49
PubMed Web of Science ®Google Scholar
Lovinger DM, Zhou Q. Alcohols potentiate ion current mediated by recombinant 5-HT3RA receptors expressed in a mammalian cell line. Neuropharmacology 1994;33:1567-72
PubMed Web of Science ®Google Scholar
Mihic SJ. Acute effects of ethanol on GABAA and glycine receptor function. Neurochem Int 1999;35:115-23
PubMed Web of Science ®Google Scholar
Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993;18:247-91
PubMed Web of Science ®Google Scholar
Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 1995;38:95-137
PubMed Web of Science ®Google Scholar
Higley JD, Suomi SS, Linnoila M. A non-human primate model of type II excessive alcohol consumption, part 1 & 2. Alcohol Clin Exp Res 1996;20:629-50
PubMed Web of Science ®Google Scholar
Carter J, Mofenson H, Carraccio T, et al. Gamma-hydroxybutyrate use – New York and Texas, 1995–1996. MMWR Morb Mortal Wkly Rep 1997;46:281-83
PubMedGoogle Scholar
Addolorato G, Abenavoli L, Leggio L, Gasbarrini G. How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review. Neuropsychobioly 2005;51:59-66
PubMed Web of Science ®Google Scholar
Heilig M, Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther 2006;111:855-76
PubMed Web of Science ®Google Scholar
Swift R. Emerging approaches to managing alcohol dependence. Am J Health Syst Pharm 2007;64(Suppl 3):S12-22
PubMed Web of Science ®Google Scholar
Garbutt JC. The state of pharmacotherapy for treatment of alcohol dependence. J Subst Abuse Treat 2009;36:S15-23
PubMed Web of Science ®Google Scholar
Schuckit MA. Alcohol-use disorders. Lancet 2009;373:492-501
PubMed Web of Science ®Google Scholar
Johnson BA, Swift RM, Addolorato G, et al. Safety and efficacy of GABAergic medications for treating alcoholism. Alcohol Clin Exp Res 2005;29:248-54
PubMed Web of Science ®Google Scholar
Beghè F, Carpanini MT. Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependents patients. Alcohol 2000;20:223-5
PubMed Web of Science ®Google Scholar
Snead OC, Morley BJ. Ontogeny of gamma-hydroxybutyric acid: regional concentration in developing rat, monkey and human brain. Brain Res 1981;227:579-89
PubMedGoogle Scholar
Wong CGT, Gibson KM, Snead OC 3rd. From the street to the brain: neurobiology of the recreational drug g-hydroxybutyric acid. Trends Pharmacol Sci 2004;25:29-34
PubMed Web of Science ®Google Scholar
Vayer P, Mandel M, Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci 1987;41:1547-57
PubMed Web of Science ®Google Scholar
Hösli L, Hösli E, Lehmann R, et al. Action of gamma-hydroxybutyrate and GABA on neurones of cultured rat central nervous system. Neurosci Lett 1983;37:257-60
PubMed Web of Science ®Google Scholar
Carter LP, Koek W, France CP. Behavioral analyses of GHB: receptor mechanisms. Pharmacol Ther 2009;121:100-14
PubMed Web of Science ®Google Scholar
Benavides J, Rumigny JF, Bourguignon JJ, et al. High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Sci 1982;30:953-61
PubMed Web of Science ®Google Scholar
Snead OC 3rd, Liu CC. Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem Pharmacol 1984;33:2587-90
PubMed Web of Science ®Google Scholar
Andriamampandry C, Taleb O, Viry S, et al. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). FASEB J 2003;17:1691-3
PubMed Web of Science ®Google Scholar
Andriamampandry C, Taleb O, Kemmel V, et al. Cloning and functional characterization of a gamma-hydroxybutyrate receptor identified in the human brain. FASEB J 2007;21:885-95
PubMed Web of Science ®Google Scholar
Kemmel V, Miehe M, Roussel G, et al. Immunohistochemical localization of a GHB receptor-like protein isolated from rat brain. J Comp Neurol 2006;498:508-24
PubMed Web of Science ®Google Scholar
Carai MAM, Colombo G, Brunetti G, et al. Role of GABAB receptors in the sedative/hypnotic effect of γ-hydroxybutyric acid. Eur J Pharmacol 2001;428:315-21
PubMed Web of Science ®Google Scholar
Carai MAM, Colombo G, Reali R, et al. Central effects of 1, 4-butanediol are mediated by GABAB receptors via its conversion into γ-hydroxybutyric acid. Eur J Pharmacol 2002;441:157-63
PubMed Web of Science ®Google Scholar
Greiner C, Röhl JE, Ali-Gorji A, et al. Different actions of γ-hydroxybutyrate: a critical outlook. Neurol Res 2003;25:759-63
PubMed Web of Science ®Google Scholar
Nava F, Carta G, Bortolato M, Gessa GL. Gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors. Eur J Pharmacol 2001;430:261-3
PubMed Web of Science ®Google Scholar
Bessmann SP, Fishbein WM. Gamma-hydroxybutyric, a normal brain metabolite. Nature 1963;200:1207-8
PubMed Web of Science ®Google Scholar
Laborit H, Jouany JM, Gerard J, Fabiani F. Summary of an experimental and clinical study on a metabolic substrate with inhibitory central action: sodium 4-hydroxybutyrate. Presse Med 1960;68:1867-9
PubMed Web of Science ®Google Scholar
Aldrete JA, Barnes DP. 4-hydroxybutyrate anaesthesia for cardiovascular surgery. A comparison with halothane. Anaesthesia 1968;23:558-65
PubMed Web of Science ®Google Scholar
Kleinschmidt S, Grundmann U, Janneck U, et al. Total intravenous anaesthesia using propofol, gamma-hydroxybutyrate or midazolam in combination with sufentanil for patients undergoing coronary artery bypass surgery. Eur J Anaesthesiol 1997;14:590-9
PubMed Web of Science ®Google Scholar
Kleinschmidt S, Grundmann U, Knocke T, et al. Total intravenous anaesthesia with gamma-hydroxybutyrate (GHB) and sufentanil in patients undergoing coronary artery bypass graft surgery: a comparison in patients with unimpaired and impaired left ventricular function. Eur J Anaesthesiol 1998;15:559-64
PubMed Web of Science ®Google Scholar
Mamelak M, Escriu JM, Stokan O. The effects of γ-hydroxybutyrate on sleep. Biol Psychiatry 1977;2:273-88
Google Scholar
Mamelak M, Scharf MB, Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 1986;9:285-9
PubMed Web of Science ®Google Scholar
Broughton R, Mamelak M. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy. Can J Neurol Sci 1980;7:23-31
PubMed Web of Science ®Google Scholar
Leggio L, Kenna GA, Swift RM. New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1106-17
PubMed Web of Science ®Google Scholar
Poldrugo F, Addolorato G. The role of gamma-hydroxybutyric acid (GHB) in the treatment of alcoholism: from animal to clinical studies. Alcohol Alcohol 1999;34:15-24
PubMed Web of Science ®Google Scholar
Gessa GL, Agabio R, Carai MAM, et al. Mechanism of the antialcohol effect of gammahydroxybutyric acid. Alcohol 2000;20:271-6
PubMed Web of Science ®Google Scholar
Fadda F, Colombo G, Mosca E, Gessa GL. Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats. Alcohol Alcohol 1989;24:447-51
PubMed Web of Science ®Google Scholar
Gessa GL, Agabio R, Carai MA, et al. Mechanism of the antialcohol effect of gamma-hydroxybutyric acid. Alcohol 2002;20:271-6
Web of Science ®Google Scholar
Agabio R, Colombo G, Loche A, et al. Gamma-hydroxybutyric acid reducing effect on ethanol intake: evidence in favour of a substitution mechanism. Alcohol Alcohol 1998;33:465-74
PubMed Web of Science ®Google Scholar
Gallimberti L, Canton G, Gentile N, et al. Gamma-hydroxybutyric acid for the treatment of alcohol withdrawal syndrome. Lancet 1989;2:787-9
PubMed Web of Science ®Google Scholar
Korninger C, Roller RE, Lesch OM. Gamma-hydroxybutyric acid in the treatment of alcohol withdrawal syndrome in patients admitted to hospital. Acta Med Austriaca 2003;3:83-6
Google Scholar
Addolorato G, Balducci G, Capristo E, et al. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Alcohol Clin Exp Res 1999;23:1596-604
PubMed Web of Science ®Google Scholar
Sullivan JT, Sykora K, Schniederman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989;84:1353-7
PubMedGoogle Scholar
Nava F, Premi S, Manzato E, et al. Gamma-hydroxybutyrate reduces both withdrawal syndrome and hypercortisolism in severe abstinent alcoholics: an open study vs. diazepam. Am J Drug Alcohol Abuse 2007;33:379-92
PubMed Web of Science ®Google Scholar
Nimmerrichter AA, Walter H, Gutierrez-Lobos KE, Lesch OM. Double blind controlled trial of γ-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal. Alcohol Alcohol 2002;37:67-73
PubMed Web of Science ®Google Scholar
Gessa GL, Crabai F, Yargiu L, Spano PF. Selective increase of brain dopamine induced by gamma-hydroxybutyrate: study of the mechanism of action. J Neurochem 1968;15:377-81
PubMed Web of Science ®Google Scholar
Biggio G, Cibin M, Diana M, et al. Suppression of voluntary ethanol intake in rats and alcoholics by gamma-hydroxybutyric acid: a non-GABAergic mechanism. Adv Biochem Psychopharmacol 1992;47:281-8
PubMedGoogle Scholar
Gallimberti L, Ferri M, Ferrara SD, et al. γ-hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol Clin Exp Res 1992;16:673-6
PubMed Web of Science ®Google Scholar
Addolorato G, Stefanini GF, Casella G, et al. Evaluation of the therapeutic efficacy of gamma-hydroxybutyric acid in the medium-term treatment of alcoholic outpatients. Preliminary data from an open multicentric study. Alcologia Eur J Alcohol Stud 1995;7:233-6
Web of Science ®Google Scholar
Addolorato G, Castelli E, Stefanini GF, et al. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. Alcohol Alcohol 1996;31:341-5
PubMed Web of Science ®Google Scholar
Ferrara SD, Zotti S, Tedeschi L, et al. Pharmacokinetics of g-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br J Clin Pharmacol 1992;34:231-5
PubMed Web of Science ®Google Scholar
Addolorato G, Cibin M, Capristo E, et al. Maintaining abstinence from alcohol by gamma-hydroxybutyric acid. Lancet 1998;351:38
Google Scholar
Addolorato G, Cibin M, Caputo F, et al. Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients. Drug Alcohol Depend 1998;53:7-10
PubMed Web of Science ®Google Scholar
Maremmani I, Lamanna F, Tagliamonte A. Long-term therapy using GHB (sodium gamma hydroxybutyrate) for treatment-resistant chronic alcoholics. J Psychoactive Drugs 2001;33:135-42
PubMed Web of Science ®Google Scholar
Thai D, Dyer JE, Benowitz NL, et al. Gamma-hydroxybutyrate and ethanol effects and interactions in humans. J Clin Psychopharmacol 2006;26:524-9
PubMed Web of Science ®Google Scholar
Caputo F, Stoppo M, Vignoli T, et al. Use of alcohol during the treatment of alcohol dependence with gamma-hydroxybutyric acid: risk of severe events are avoided by the dose fractioning of the drug. J Clin Psychopharmacol 2007;27:418
PubMed Web of Science ®Google Scholar
Caputo F, Addolorato G, Lorenzini F, et al. Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study. Drug Alcohol Depend 2003;70:85-91
PubMed Web of Science ®Google Scholar
Nava F, Premi S, Manzato E, Lucchini A. Comparing treatments of alcoholism on craving and bio-chemical measures of alcohol consumptions. J Psychoactive Drugs 2006;38:211-17
PubMed Web of Science ®Google Scholar
Caputo F, Addolorato G, Stoppo M, et al. Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study. Eur Neuropsychopharmacol 2007;17:781-9
PubMed Web of Science ®Google Scholar
Caputo F, Vignoli T, Lorenzini F, et al. Suppression of craving for γ-hydroxybutyric acid by naltrexone administration: three case reports. Clin Neuropharmacol 2005;28:87-9
PubMed Web of Science ®Google Scholar
Stella L, Addolorato G, Rinaldi B, et al. An open randomized study of the treatment of escitalopram aloneand combined with γ-hydroxybutyric acidand naltrexone in alcoholic patients. Pharmacol Res 2008;57:312-17
PubMed Web of Science ®Google Scholar
Leggio L, Addolorato G. The serotonin transporter (SERT) brain density and the neurobiological Cloninger subtypes model: a lesson by human autoradiography studies. Alcohol Alcohol 2008;43:148-50
PubMed Web of Science ®Google Scholar
Leggio L, Kenna GA, Fenton M, et al. Typologies of alcohol dependence from Jellinek to genetics and beyond. Neuropsychol Rev 2009;19:115-29
PubMed Web of Science ®Google Scholar
Caputo F, Francini S, Stoppo M, et al. Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study. J Psychopharmacol 2009; published online 17 July 2008, doi:10.1177/0269881108094620
PubMedGoogle Scholar
Chin MY, Kreutzer RA, Dyer JB. Acute poisoning from gamma-hydroxybutyrate in California. West J Med 1992;156:380-4
PubMedGoogle Scholar
Tunnicliff G. Site of action of Gamma-hydroxybutyrate (GHB) – a neuroactive drug with abuse potential. J Toxicol Clin Toxicol 1997;35:581-90
PubMed Web of Science ®Google Scholar
Louagie HK, Verstraete AG, De Soete CJ, et al. A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol. J Toxicol Clin Toxicol 1997;35:591-4
PubMed Web of Science ®Google Scholar
GHB follows ketamine as UK rave scene embraces downer drugs. Druglink 1994;9:5
Google Scholar
Thomas G, Bonner S, Gascoigne A. Coma induced by abuse of gamma-hydroxybutyrate (GHB or liquid ecstasy): a case report. Br Med J 1997;314:35-6
PubMed Web of Science ®Google Scholar
Nicholson KL, Balster RL. GHB: a new and novel drug of abuse. Drug Alcohol Depend 2000;63:1-22
Web of Science ®Google Scholar
Marwick C. Coma inducing drug GHB may be reclassified. JAMA 1997;277:1505-6
PubMed Web of Science ®Google Scholar
Drasbek KR, Christensen J, Jensen K. Gamma-hydroxybutyrate – a drug of abuse. Acta Neurol Scand 2006;114:145-56
PubMed Web of Science ®Google Scholar
Friedman J, Westlake R, Furman M. ‘Grievous bodily harm’: gamma hydroxybutyrate abuse leading to the Wernicke-Korsakoff syndrome. Neurology 1996;46:469-71
PubMed Web of Science ®Google Scholar
Addolorato G, Capristo E, Gessa GL, et al. Long-term administration of GHB does not affect muscular mass in alcoholics. Life Sci 1999;65:191-6
Web of Science ®Google Scholar
Liechti ME, Kunz I, Greminger P, et al. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend 2006;81:323-6
PubMed Web of Science ®Google Scholar
Sumnall HR, Woolfall K, Edwards S, et al. Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug Alcohol Depend 2008;92:286-90
PubMed Web of Science ®Google Scholar
Kam PCA, Yoong FFY. Gamma-hydroxybutyric acid: an emerging recreational drug. Anaesthesia 1998;53:1195-8
PubMed Web of Science ®Google Scholar
Dyer J. Gamma-hydroxybutyrate: a health food product producing coma and seizure-like activity. Am J Emerg Med 1991;9:321-4
PubMed Web of Science ®Google Scholar
Dyer JE, Roth B, Hyma BA. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med 2001;37:147-53
PubMed Web of Science ®Google Scholar
Bennett WR, Wilson LG, Roy-Byrne PP. Gamma-hydroxybutyric acid (GHB) withdrawal: a case report. J Psychoactive Drugs 2007;39:293-6
PubMed Web of Science ®Google Scholar
Food and Drug Administration. Warning about GHB. JAMA 1991;265:1802
PubMed Web of Science ®Google Scholar
Tunnicliff G, Raess BU. Gamma-Hydroxybutyrate (orphan medical). Curr Opin Investig Drugs 2002;3:278-83
PubMedGoogle Scholar
Gallimberti L, Spella MR, Soncini CA, Gessa GL. Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol 2000;20:257-62
PubMed Web of Science ®Google Scholar
Addolorato G, Caputo F, Capristo E, et al. A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration. Clin Neuropharmacol 1999;22:60-2
PubMed Web of Science ®Google Scholar
Addolorato G, Leggio L, Abenavoli L, et al. Gamma hydroxybutyric acid (GHB) withdrawal does not occur at therapeutic dosage. Drug Alcohol Depend 2005;77:209
PubMed Web of Science ®Google Scholar
McDonough M, Kennedy N, Glasper A, Bearn J. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend 2004;75:3-9
PubMed Web of Science ®Google Scholar
Addolorato G, Caputo F, Capristo E, et al. Gamma-hydroxybutyric acid efficacy, potential abuse, and dependence in the treatment of alcohol addiction. Alcohol 2000;20:217-22
PubMed Web of Science ®Google Scholar
Johnson BA, Rosenthal N, Capece JA, et al. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 2007;298:1641-51
PubMed Web of Science ®Google Scholar
Addolorato G, Leggio L, Ferrulli A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 2007;370:1915-22
PubMed Web of Science ®Google Scholar
Furieri FA, Nakamura-Palacios EM. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2007;68:1691-700
PubMed Web of Science ®Google Scholar
Hines LM. Ray L, Hutchison K, Tabakoff B. Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci 2007;7:153-63
Google Scholar
Edenberg HJ, Kranzler HR. The contribution of genetics to addiction therapy approaches. Pharmacol Ther 2005;108:86-93
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date